Annovis Bio, Inc. ANVS
1.31
(0.02)
(1.50%)
as of 25 Sep
- Market cap
- $56.8M
- P/E
- 0.0×
Follow ANVS
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Current Ratio |
3.47 | 1.27 | 5.80 | 4.60 |
+8 more quarters Free account |
Net Debt/EBITDA |
1.30 | 0.79 | 2.01 | 2.06 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
1.48 | 0.51 | 0.91 | 0.48 | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow per Share |
(0.58) | (0.32) | (0.43) | (0.18) | |
Cash per Share |
0.50 | 0.51 | 0.95 | 0.78 | |
Shareholders Equity per Share |
(0.11) | 0.11 | 0.82 | 0.67 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
(0.11) | 0.11 | 0.82 | 0.67 | |
Free Cash Flow |
(21.91) | (9.01) | (8.93) | (3.49) | |
Working Capital |
15.68 | 3.45 | 17.45 | 13.46 | |
Net Current Asset Value |
(4.25) | 3.13 | 16.85 | 13.16 | |
| Other line items | |||||
Quick Ratio |
2.95 | 1.11 | 5.37 | 4.09 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.58) | (0.32) | (0.43) | (0.18) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Payables |
2.15 | 3.32 | 2.45 | 3.11 | |
Average Assets |
21.75 | 21.49 | 17.50 | 15.78 | |
Average Common Equity |
7.04 | 13.59 | 13.08 | 10.11 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates